EpiHeart is the older company (2019 vs 2020); Reprieve Cardiovascular is the larger of the two.
Side-by-Side Comparison
| Metric | EpiHeart | Reprieve Cardiovascular |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2020 |
| Headquarters | ||
| Headquarters | Helsinki, Finland | Milford, United States |
| Employees | ||
| Employees | 5 | 24 larger |
| Industry | ||
| Industry | Health Care, Manufacturing | Health Care, Health and Wellness, Medical Devices |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series A |
| Total Funding | ||
| Total Funding | Not tracked yet | $91.05M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 5 |
| Services | ||
| Services | Cardiac Micrograft Therapy, Development of advanced cardiac cell therapies, Clinical study collaboration | Not tracked yet |
| Target Customers | ||
| Target Customers | Cardiac surgery units, Research institutions, Medical distributors, Healthcare professionals specializing in cardiac care | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cardiac Cellular Therapy, Medical Device Company, Ischemic Injury Repair, CABG, LVAD Surgery, Heart Failure Treatment, Cellular And Gene Therapies, Ischemic Cardiac Scars, Surgical Administration, Cardiac Treatment Innovation, Novel Therapies, Cardiac Surgery Integration | Cardiovascular Health, Heart Failure Treatment, Medical Device Company, Decongestion Management, Clinical Trials, Innovative Therapies, Acute Decompensated Heart Failure, Medical Technology, Fluid Removal Therapy, Healthcare Innovation |
| Website | ||
| Website | epiheart.com | reprievecardio.com |
About EpiHeart
EpiHeart, founded in 2019 and based in Finland, is a promising player in the Health Care and Manufacturing sectors. Their focus is clear: enabling surgical administration of cutting-edge cellular and gene therapies aimed particularly at cardiac care. Their innovation seeks to address significant ch...
About Reprieve Cardiovascular
Reprieve Cardiovascular is a health care startup that aims to revolutionize the treatment of heart failure, potentially benefiting over 25 million patients worldwide. The company is focused on developing innovative therapies to bring intelligence to decongestion management, with the goal of safely a...
We will tell you when either one moves
BounceWatch watches EpiHeart and Reprieve Cardiovascular for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at EpiHeart and Reprieve Cardiovascula... — by email.
Frequently Asked Questions
Compare EpiHeart with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at EpiHeart on 13 Nov 2025, and Reprieve Cardiovascular on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
